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Case Report
Erythema ab igne: Toasted Skin Syndrome
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Introduction

Erythema ab igne is a benign skin condition caused by long-term exposure to infrared radiation and/or heat. Erythema ab igne begins as a mild erythema over the previously exposed
areas and develops into an erythematous reticulated hyperpigmentation with scaling and
telangiectasias.
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Clinical Findings

A 55-year-old female presented to the primary care clinic with concerns due to the development of a rash on her lower back in the previous 1 to 2 weeks. She had a history of chronic
back pain and was using conservative treatment for pain management, including daily use
of a heating pad for 15 minutes every hour.
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Interventions

There is no definitive therapy for erythema ab igne. Elimination of the heat source may
reverse the erythema and hyperpigmentation.
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Outcome

The patient was counseled regarding the importance of limiting and/or discontinuing the
use of the heating pad to facilitate resolution of the rash. The patient did not return to the
clinic and resolution of the rash was not confirmed.
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Introduction

Erythema ab igne (erə’THēmə ab ignē) is a
benign skin condition caused by long-term
exposure to infrared radiation or heat. In Latin,
it translates to “redness by fire”.1,2 This condition
has many other names such as hitze melanoses
(German for “melanosis induced by heat”),
ephelis ignealis, heat-induced circumscribed
dermal melanosis, livedo reticularis e calore and
toasted skin syndrome.2
Erythema ab igne begins as a mild erythema
over the previously heat-exposed areas and develops into an erythematous, reticulated hyperpigmentation with scaling and telangiectasias
present over the same area.3 Generally, the rash
is reported to be asymptomatic and often is
an incidental finding. Diagnosis of this derma-

tological condition is based on clinical findings
and supporting history.
Historically, erythema ab igne has been associated with occupations that experience prolonged exposure to heat, such as bakers and
metal foundry workers.4 It was also common
in individuals with chronic exposures to fires
prior to the development of central heating.4
The temperature required to produce the
rash is lower than what is required to cause a
burn, typically between 43 and 47°C or 107.6
and 116.6°F.5,6 With the increasing use of portable electronic technologies, there have been
reported cases associated with exposure to
heated car seats, heating pads, space heaters,
hot laptops or hot water bottles.5
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Figure 1. Examination of the rash demonstrated diffuse erythema with hyperpigmented reticulated telangiectasia.

Case Presentation

This case pertains to a 55-year-old female with
a history of chronic back pain, fibromyalgia and
morbid obesity. The pain had been located in
the middle to lower back and did not radiate
but was increasing in intensity and frequency. The patient lived a sedentary lifestyle but
reported less mobility secondary to her worsening back pain. The patient was status-post
thoracolumbar nerve block injection 4 months
prior and had plans for a repeat injection.
She presented to the primary care clinic with
concerns due to the development of a rash on
her lower back over the previous 1 to 2 weeks.
(Figure 1) The patient expressed worry that the
rash would prevent her from receiving a second
injection for back pain symptom management.
She denied recent trauma or osteopathic/
chiropractic manipulation. She noted she was
seated or lying in bed for 20 to 22 hours a day.
The patient was using conservative treatment
for pain management, including a heating pad
on her back. She reported attempting to keep
the heating pad applied for only 15 minutes but
often was applying the heating pad every hour
throughout the day. Besides cosmetic concerns, the rash was asymptomatic.
The patient was counseled regarding the importance of limiting or discontinuing the use of
the heating pad to facilitate resolution of the
98

rash. The patient did not return to the clinic
and resolution of the rash was not confirmed.
Additionally, due to the lack of follow-up to obtain a biopsy if necessary, a definitive diagnosis
of erythema ab igne was not possible.

Treatment

There is no definitive therapy for erythema ab
igne. Elimination of the heat source may reverse the erythema and hyperpigmentation.5,7
For cases that are chronic or improve minimally
after elimination of the heat source, the use
of topical steroids or tretinoin and hydroquinone may reduce the discoloration.7 Five-fluorouracil has been shown to help destroy the
atypical cells that make up the reticulated rash
of erythema ab igne.7 Mesoglycan with topical
flavonoids has also been shown to reduce the
discoloration.8-10

Discussion

A review of the literature found the majority of
cases were reported in middle-aged to elderly
adults suffering from chronic musculoskeletal
pain, with lesions appearing after application of
hot water bottles or heating pads.1-17 In younger
adult and pediatric populations, the incidence
of erythema ab igne was more frequently associated with the use of heat-generating portable electronic devices such as laptops or space
heaters.1,11
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The pathophysiology of the rash has not been
fully established, but some studies indicate
that thermal radiation exposure induces damage to the superficial blood vessels, which leads
to epidermal vascular dilation.11 The hyperpigmentation, which can occur in a reticular
distribution, is thought to be due to deposition
of hemosiderin.4,12,13 One study that obtained
biopsies for pathological evaluation proposed
radiant (infrared) energy enters the dermis
and activates lysosomes.2 The enzymes become free to diffuse into the tissue and digest
susceptible substances such as collagens and
elastic fibers. These condense with chronic
exposure and produce elastosis or degenerative
changes with increased deposition of elastin,
resulting in the classic characteristic rash of
erythema ab igne.2 Other theories attribute the
rash to repeated exposures to infrared radiation. The repeated exposures lead to a marked
erythema, hyperpigmentation and occasional
epidermal atrophy.14
Histologically, erythema ab igne resembles
actinic keratosis with the epidermis showing
atypical cells. There is also associated accumulation of dermal elastic tissue, which is an early
sign of both UV radiation and heat-induced
skin damage.14
Erythema ab igne can resemble other skin
conditions, including livedo reticularis, livedo
racemose, cutis mamorata and cutis marmorata telanglectasia.9,15 Livedo reticularis is characterized by a mottled reticular pattern and often
has purple discoloration. These findings are due
to impaired blood flow and occurs after exposure to cold temperature. These symptoms will
resolve as the tissue rewarms.9 Like erythema
ab igne, livedo racemose is also characterized
by a violaceous net-like rash, but the rash is
more widespread as opposed to being limited
to a specific exposed area. Additionally, the
shape is irregular, and this skin condition is also
commonly associated with pathological conditions.16
Cutis marmorata is the physiological form of
livedo reticularis and is a normal response of
the body.9 This form is often seen in infants
and resolves with age. Livedo reticularis may
be indicative of underlying pathology, including lupus, vasculitis, toxins, etc. These types of
pathology are differentiated from erythema

ab igne since cold exposure causes the discoloration as opposed to warm exposure in
erythema ab igne.9 Cutis marmorata telangiectasia is characterized by persistent reticulated
blanching erythema with possible atrophy. This
condition is congenital and can be associated
with vascular malformation, limb asymmetry,
neurologic or ocular abnormalities. One distinguishing feature includes occasional ulceration
development along the lines of atrophy. Additionally, due to its congenital nature, it can
be accompanied by other anomalies including
syndactyly, port-wine stain, clubfoot, etc.9,13
Although erythema ab igne is largely a benign
incidental finding, there are reports of associated insidious pathologies. There have been
reported cases of erythema ab igne developing
cutaneous malignancies such as squamous cell
carcinoma or Merkel cell carcinoma.5,17 In other
studies, erythema ab igne was a dermatological finding in patients with underlying malignancies such as colorectal, pancreatic, gastric,
renal, breast and/or hematologic malignancies.3
It has been suggested that the underlying
malignancy may serve as the source of chronic
pain that leads patients to use heating devices
that will lead to development of the rash.17

Conclusion

Heat is often recommended by physicians as
conservative treatment for musculoskeletal or
chronic pain. It is important to consider erythema ab igne as a potential complication when
recommending this relatively benign treatment
or as a potential diagnosis in patients with
an unexplained rash who are utilizing heating
modalities for pain control. With increasing
use of portable electronics, practitioners need
to revisit safe practice guidelines of heatgenerating technologies. Differentiating this
benign condition from similar looking rashes
will ultimately prevent exposing patients to
unnecessary testing, costly treatment and
unnecessary referrals to specialists. Due to the
risk of underlying malignancies associated with
erythema ab igne, it is important the condition
is properly diagnosed and followed in the primary care setting.
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